Mycenax Biotech Inc.

11/12/2024 | Press release | Distributed by Public on 11/12/2024 01:26

Announcement of the capital increase record date for the conversion of employee stock options to common stocks.

Close
Today's Information

Provided by: Mycenax Biotech Inc.
SEQ_NO 2 Date of announcement 2024/11/12 Time of announcement 15:21:32
Subject
 Announcement of the capital increase record date
for the conversion of employee stock options to common
stocks.
Date of events 2024/11/12 To which item it meets paragraph 11
Statement
1.Date of the board of directors resolution:2024/11/12
2.Source of capital increase funds:Conversion of employee stock options to
common stocks.
3.Whether to adopt shelf registration
  (Yes, please state issuance period/No):No
4.Total monetary value of the issuance and number of shares issued (shares
 issued not including those distributed to employees if consisting in
 capital increase from earnings or capital surplus):
The total issuance amount is NT$ 5,087,000, and the number of
shares issued is 508,700 shares.
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:N/A
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:N/A
7.Par value per share:NT$10
8.Issue price:The issuance price is NT$20.8 or NT$36.1.
9.Number of shares subscribed for by or allocated to employees:508,700 shares
10.Number of shares publicly sold:N/A
11.Ratio of shares subscribed by or allotted as stock
dividends to existing shareholders:N/A
12.Handling method for fractional shares and shares
unsubscripted for by the deadline:N/A
13.Rights and obligations of these newly issued shares:
Same as the original common stocks
14.Utilization of the funds from the capital increase:N/A
15.Any other matters that need to be specified:
The capital increase record date is set on 2024/11/12.